Literature DB >> 11236824

Activation mechanism of brain microglia in patients with diffuse neurofibrillary tangles with calcification: a comparison with Alzheimer disease.

K Imamura1, M Sawada, N Ozaki, H Naito, N Iwata, R Ishihara, T Takeuchi, H Shibayama.   

Abstract

Diffuse neurofibrillary tangles with calcification (DNTC) is an atypical dementia and is characterized pathologically by diffuse neurofibrillary tangles (NFTs) without senile plaques (SPs). In this study, we investigated the distribution of human leukocyte antigen (HLA)-DR-positive activated microglia in postmortem brain tissue of six patients with DNTC and six patients with Alzheimer disease (AD). HLA-DR-positive activated microglia were observed to associate with SPs in AD. In the DNTC brain, which lacks SPs, HLA-DR-positive microglia were mainly accumulated around weakly tau-positive NFTs, which were also positive for anti-amyloid-P and anti-C3d antibodies. The results of this study suggest that the complement pathway is also activated in the DNTC brain and that immune and inflammatory responses, including microglia activation, may occur around extracellular NFTs in DNTC patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11236824     DOI: 10.1097/00002093-200101000-00006

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  3 in total

1.  Isoliquiritigenin Reduces LPS-Induced Inflammation by Preventing Mitochondrial Fission in BV-2 Microglial Cells.

Authors:  Dong Gil Lee; Bo Ra Nam; Jae-Won Huh; Dong-Seok Lee
Journal:  Inflammation       Date:  2020-11-05       Impact factor: 4.092

2.  Markers of microglia in post-mortem brain samples from patients with Alzheimer's disease: a systematic review.

Authors:  K E Hopperton; D Mohammad; M O Trépanier; V Giuliano; R P Bazinet
Journal:  Mol Psychiatry       Date:  2017-12-12       Impact factor: 15.992

3.  Trafficking of immune cells across the blood-brain barrier is modulated by neurofibrillary pathology in tauopathies.

Authors:  Petra Majerova; Alena Michalicova; Martin Cente; Jozef Hanes; Jozef Vegh; Agnes Kittel; Nina Kosikova; Viera Cigankova; Sandra Mihaljevic; Santosh Jadhav; Andrej Kovac
Journal:  PLoS One       Date:  2019-05-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.